国际标准期刊号: 2278-0238

国际药学与生命科学研究与发展杂志

开放获取

我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

抽象的

ENHANCEMENT OF SOLUBILITY OF POORLY WATER SOLUBLE DRUGS DICLOFENAC SODIUM BY MIXED SOLVENCY APPROACH

Masheer Ahmed Khan

Enhancement of solubility is one of the difficult tasks which become challenges in formulation development of orally administered drug with poor aqueous solubility. Poor water solubility of drugs often causes significant problems in producing formulations of sufficiently high bioavailability, preventing effective use of the drugs. 'Mixed-solvency ' concept is the phenomenon to increase the solubility of poorly water-soluble drugs in the aqueous solution containing blends of hydrotropic agents, co-solvents and water soluble solutes which may give synergistic enhancement effect on solubility of such drugs. In the present investigation , mixed solvency approach has been applied for the enhancement of aqueous solubility of a poorly water- soluble drugs diclofenec sodium (selected as a model drug), by making blends of randomly selected water-soluble substances from among the hydrotropic (urea, sodium acetate); water soluble solutes (PEG4000, PEG6000); and co-solvents (PEG200, PEG400). The aqueous solubility of diclofenac sodium was observed at room temperature in the randomly selected blends of solubilizers containing different combinations keeping total concentration 50%w/v constant. Diclofenec sodium have λmax 276 nm and obeys Beers Law in concentration range of 10-60 μg/ml. The results suggest that solubility of the diclofenac sodium containing blends of varying combinations was enhanced significantly using mixed solvency approach.

免责声明: 此摘要通过人工智能工具翻译,尚未经过审核或验证。